Melanoma Genel Bakış

Parlak A

Article Details

Melanoma Genel Bakış

Authors:

Parlak A

Publisher:

Duzce University

Journal:

Konuralp Medical Journal 2014 Vol.6 Issue 1, pp.22-27

Document Type:

Article

Publication Date:

3/2014

Document Language:

Turkish

Document ID (Org No.):

2000538641

Frequency:

Tri-annual

eISSN:

1309-3878

pISSN:

1309-3878

Abstract:

 

ABTRACT Cutaneous melanoma is a malignancy which has an increasing  incidence in all over the world especially due to increased UV exposure.  Although it builds only 4% of all skin cancers, it is the major cause of  death appears to be associated with skin cancer. As the disease  progresses both cost of the treatment and worsening of the prognosis  increases. Local excision of melanomas detected at an early stage may  provide over 90% cure on the other hand despite surgery and  chemotherapy 5-year survival rate of treatment of advanced-stage  melanomas is about 20%. Melanoma staging is important in  determining treatment planning and prognosis of patients. Different  systems have been developed for staging melanoma to date but most of  them considered inadequate. In parallel with developments in science,  innovations in imaging and genetic studies brought a number of changes  in the treatment and staging of melanoma. Some drugs which has been  tried in the early nineties, now taken its place today as part of the  treatment. Prognostic factors and treatment regimens considered to be  effective on survival have uncovered with a number of studies. In this  article it is intended to increase awareness of health care workers about  cutaneous melanoma. In addition, the current staging system for  melanoma, treatment modalities and factors thought to be effect on  prognosis will be mentioned.

 

Kutanöz melanom özellikle artan UV maruziyeti nedeniyle insidansı tüm dünyada artış gösteren bir malignitedir. Tüm deri kanserlerinin yalnızca %4’ünü oluşturmasına rağmen deri kanserleri ile ilişkili ölümlerin başlıca nedeni olarak karşımıza çıkmaktadır. Hastalık ilerledikçe hem prognozu kötüleşmekte hem de tedavi maliyeti artmaktadır. Erken evrede saptanabilen melanomlarda lokal eksizyon ile %90’ın üzerinde tedavi sağlanabilirken ileri evre melanomlarda 5 yıllık sağ kalım oranı cerrahi ve kemoterapi uygulamasına rağmen ancak %20 civarındadır. planlanması ve prognozlarının tayininde önemlidir. Bugüne kadar evrelemesi.

Article Details

Melanoma Genel Bakış

Authors: Parlak A

Publisher: Duzce University

Journal: Konuralp Medical Journal 2014 Vol.6 Issue 1, pp.22-27

Document Type: Article

Publication Date: 3/2014

Document Language: Turkish

Document ID (Org No.): 2000538641

Frequency: Tri-annual

eISSN: 1309-3878

pISSN: 1309-3878

Issues

Authors:

Parlak A

Publisher:

Duzce University

Journal:

Konuralp Medical Journal 2014 Vol.6 Issue 1, pp.22-27

Document Type:

Article

Publication Date:

3/2014

Document Language:

Turkish

Document ID (Org No.):

2000538641

Frequency:

Tri-annual

eISSN:

1309-3878

pISSN:

1309-3878